Egypt's new drug prices may lead to hikes

The Egyptian Drug Authority has launched a new system for setting medicine prices, which is linked to three economic indicators: the exchange rate (60%), inflation (30%), and interest rates (10%). The system aims to achieve market balance and protect patients' rights, with reviews every six months. Prices can be adjusted if they increase or decrease by at least 10% over a period of 45 days. This system is expected to help regulate drug prices and reduce excessive increases, but it also raises concerns about its impact on the availability of medications and the rising financial burden on patients, especially those who are unable to afford them, due to price fluctuations and the need to consider international cost and price benchmarks.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل